- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it will hold a conference call and webcast on Thursday November 13, 2008 at 8:00 am Pacific Time (11:00 am Eastern Time) to discuss third quarter 2008 operating results and to provide an update on developments at the Company.
About the Conference Call
To participate in the conference call, please dial 416-641-6139 or 1-866-299-6657. The call will be available for replay until November 27, 2008 by calling 416-695-5800 or 1-800-408-3053 and entering the code 3275046.
The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com.
About Tekmira Pharmaceuticals Corporation
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi products and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira is based in Vancouver, B.C.
For more information, please click here
Tekmira Pharmaceuticals Corporation - Investors
Executive Vice President Finance and Chief Financial Officer
Longview Communications Inc.
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017
National Conference on Nanomaterials, (NCN-2017) April 21st, 2017
Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017
Forge Nano 2017: 1st Quarter Media Update April 20th, 2017